Study in Subjects Undergoing Complete Abdominoplasty
Status:
Completed
Trial end date:
2019-06-12
Target enrollment:
Participant gender:
Summary
Phase 2, single center, randomized, double-blind, placebo-controlled, parallel design study
of CA-008 vs. placebo in subjects undergoing an elective C-ABD under general anesthesia
supplemented with a bupivacaine hydrochloride (HCl)transverse abdominis plane (TAP) block.